Search Results - "Uldrick, T. S"

A20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi’s sarcoma-associated herpesvirus vFLIP oncoprotein by Sakakibara, S, Espigol-Frigole, G, Gasperini, P, Uldrick, T S, Yarchoan, R, Tosato, G

“…Kaposi’s sarcoma-associated herpesvirus (KSHV) K13/vFLIP (viral Flice-inhibitory protein) induces transcription of numerous genes through NF-κB activation,…”
Get full text

An evaluation of the early effects of a combination antiretroviral therapy programme on the management of AIDS-associated Kaposi's sarcoma in KwaZulu-Natal, South Africa by Mosam, A, Uldrick, T S, Shaik, F, Carrara, H, Aboobaker, J, Coovadia, H

“…Roll-out of combination antiretroviral therapy (cART) in South Africa should impact on AIDS-associated Kaposi's sarcoma (KS). Government provision began in…”
Get more information

IMMUNE AND VIRUS‐SPECIFIC RESPONSES IN PARTICIPANTS WITH PRIMARY EFFUSION LYMPHOMA RECEIVING LENALIDOMIDE, DOSE‐ADJUSTED EPOCH, AND RITUXIMAB (EPOCH‐R 2 ) by Lurain, K, Roshan, R, Ramaswami, R, Mangusan, R, Widell, A, Ekwede, I, Ziegelbauer, J. M, Uldrick, T. S, Whitby, D, Yarchoan, R, Krug, L. T

Get full text

A20/TNFAIP3 inhibits NF-[kappa]B activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein by Sakakibara, S, Espigol-frigole, G, Gasperini, P, Uldrick, T S, Yarchoan, R, Tosato, G

“…Kaposi's sarcoma-associated herpesvirus (KSHV) K13/vFLIP (viral Flice-inhibitory protein) induces transcription of numerous genes through NF-κB activation,…”
Get full text

The KAART Trial: a randomized controlled trial of HAART compared to the combination of HAART and \chemotherapy in treatment-naïve patients with HIV-associated Kaposi sarcoma (HIV-KS) in KwaZulu-Natal (KZN), South Africa by Mosam, A, Shaik, F, Uldrick, TS, Friedland, GH, Scadden, DT, Aboobaker, J, Coovadia, HM

“…From: 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA 26-27 April, 2010 Author details…”
Get full text

Increasing incidence of Kaposi's sarcoma in black South Africans In Kwazulu-Natal, South Africa (1983 to 2006) by Uldrick, TS, Mosam, A, Carrara, H, Shaik, F, Berkman, A, Coovadia, HM

Get full text

Prognosis of patients with AIDS-associated Kaposi's sarcoma receiving antiretroviral therapy +/- chemotherapy in Kwazulu-Natal, South Africa: an analysis of 1-yr survival data from NCT00380770 by Uldrick, TS, Mosam, A, Shaik, F, Friedland, G, Skadden, D, Jordaan, JP, Aboobaker, J, Coovadia, HM

Get full text

A phase I dose-escalation study of azacitidine in combination with temozolomide in patients with soft tissue sarcomas by Matushansky, I., Coakley, K. E., Uldrick, T. S., Taub, R. N.

“…Abstract only…”
Get full text

COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies by Goldman, Jason D, Robinson, Philip C, Uldrick, Thomas S, Ljungman, Per

“…SARS-CoV-2 is the virus responsible for the COVID-19 pandemic. COVID-19 has highly variable disease severity and a bimodal course characterized by acute…”
Get full text

Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study by Polizzotto, Mark N, Uldrick, Thomas S, Wyvill, Kathleen M, Aleman, Karen, Peer, Cody J, Bevans, Margaret, Sereti, Irini, Maldarelli, Frank, Whitby, Denise, Marshall, Vickie, Goncalves, Priscila H, Khetani, Vikram, Figg, William D, Steinberg, Seth M, Zeldis, Jerome B, Yarchoan, Robert

“…Purpose Kaposi's sarcoma (KS) is a multicentric tumor caused by Kaposi's sarcoma-associated herpesvirus. Unmet needs include therapies that are oral,…”
Get full text

Paradoxical central nervous system immune reconstitution syndrome in acquired immunodeficiency syndrome-related primary central nervous system lymphoma by Kranick, Sarah M, Goncalves, Priscila H, Stetler-Stevenson, Maryalice, Aleman, Karen, Polizzotto, Mark N, Little, Richard F, Yarchoan, Robert, Uldrick, Thomas S

Get full text

A phase I trial of pomalidomide in combination with liposomal doxorubicin in the treatment of advanced or refractory Kaposi sarcoma in individuals with or without HIV by Ramaswami, Ramya, Lurain, Kathryn Anne, Goncalves, Priscila Hermont, Widell, Anaida, Lindsley, Matthew, Figg, William Douglas, Peer, Cody J., Steinberg, Seth M., Khetani, Vikram, Choyke, Peter L., Fontana, Joseph R, Whitby, Denise, Uldrick, Thomas S., Yarchoan, Robert

“…Abstract only…”
Get full text

Prolonged Remission Achieved in a Relapsing Idiopathic Multicentric Castleman Disease Patient with a Novel, Targeted Treatment Approach by Fajgenbaum, David C, Shilling, Dustin, Partridge, Helen L, Pierson, Sheila K, Ruth, Jason R, Nabel, Christopher Sheild, Stone, Katie, Chaturvedi, Vandana, Jordan, Michael B., Cohen, Adam D., Krymskaya, Vera, Rubenstein, Arthur H, van Rhee, Frits, Uldrick, Thomas S

“…Idiopathic multicentric Castleman disease (iMCD) is a polyclonal lymphoproliferative disorder involving cytokine-induced multiple organ dysfunction. Unlike…”
Get full text